# MediMabBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medimabbio

- Industry: Biotechnology
- Headquarters: Seongnam, South Korea
- Website: www.medimabbio.net
- Total disclosed funding: $34M
- Latest round: Series B (Oct 24, 2025)
- Investors on record: 18

## About

Founded in 2017, and based in Seongnam, South Korea, MediMabBio Inc. operates as a biotechnology firm that develops drugs and immunotherapies to treat patients with cancer. In October 2025, MediMabBio Inc. raised KRW 25.6 billion in series B funding from Yuanta Investment, Seoul Investment Partners, Sneak Peek Investment, Union Investment Partners, AON Investment, E&Venture Partners, DongBang Future Tech & Life Co., Ltd., KNOTUS, KB Investment, Smilegate Investment, BNH Investment, Hyundai Investment Partners, iM Investment Partners, and Timefolio Asset Management.

MediMabBio Inc. is a healthcare immunotherapy developer that intends to fight cancer by utilizing the power of modern biology and advanced immunological techniques. The company's primary goal is to develop effective first-in-class immuno-oncology medications capable of targeting a range of advanced and solid tumors. By doing so, they hope to overcome the current limitations of cancer immunotherapy and provide new treatment options for cancer patients.

The company will use the investment in October 2025 to further accelerate the development and commercialization of next-generation immunotherapies to the global market.

## Funding rounds

- Series B, Oct 24, 2025, $18M — KB Investment, Seoul Investment Partners, Yuanta Investment, Smilegate Investment, Timefolio Asset Management, Union Investment Partners, BNH Investment, Hyundai Investment Partners, E&Venture Partners, Sneak Peek Investment, KNOTUS, iM Investment Partners, AON Investment, DongBang Future Tech & Life Co., Ltd.
- Series A, Feb 10, 2021, $16M — KB Investment, Smilegate Investment, G.N.TECH Venture Capital, Posco Investment, BNH Investment, K-Run Ventures, Hyundai Investment Partners, Time Folio Asset Management

## Investors

- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series A, Series B
- Smilegate Investment (https://capitalatlas.ai/funds/smilegate-investment) — Series A, Series B
- G.N.TECH Venture Capital (https://capitalatlas.ai/funds/g-n-tech-venture-capital) — Series A
- Posco Investment (https://capitalatlas.ai/funds/posco-investment) — Series A
- BNH Investment (https://capitalatlas.ai/funds/bnh-investment) — Series A, Series B
- K-Run Ventures (https://capitalatlas.ai/funds/k-run-ventures) — Series A
- Hyundai Investment Partners (https://capitalatlas.ai/funds/hyundai-investment-partners) — Series A, Series B
- Time Folio Asset Management — Series A
- Seoul Investment Partners (https://capitalatlas.ai/funds/seoul-investment-partners) — Series B
- Yuanta Investment (https://capitalatlas.ai/funds/yuanta-investment) — Series B
- Timefolio Asset Management — Series B
- Union Investment Partners (https://capitalatlas.ai/funds/union-investment-partners) — Series B
- E&Venture Partners (https://capitalatlas.ai/funds/e-venture-partners) — Series B
- Sneak Peek Investment (https://capitalatlas.ai/funds/sneak-peek-investment) — Series B
- KNOTUS — Series B
- iM Investment Partners (https://capitalatlas.ai/funds/im-investment-partners) — Series B
- AON Investment (https://capitalatlas.ai/funds/aon-investment) — Series B
- DongBang Future Tech & Life Co., Ltd. — Series B